Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Cell biology of prion infection.

Priola SA.

Handb Clin Neurol. 2018;153:45-68. doi: 10.1016/B978-0-444-63945-5.00003-9.

PMID:
29887152
2.

Cell Biology Approaches to Studying Prion Diseases.

Priola SA.

Methods Mol Biol. 2017;1658:83-94. doi: 10.1007/978-1-4939-7244-9_7. Review.

PMID:
28861784
3.

Prion strains depend on different endocytic routes for productive infection.

Fehlinger A, Wolf H, Hossinger A, Duernberger Y, Pleschka C, Riemschoss K, Liu S, Bester R, Paulsen L, Priola SA, Groschup MH, Schätzl HM, Vorberg IM.

Sci Rep. 2017 Jul 31;7(1):6923. doi: 10.1038/s41598-017-07260-2.

4.

Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.

Wang F, Wang X, Orrú CD, Groveman BR, Surewicz K, Abskharon R, Imamura M, Yokoyama T, Kim YS, Vander Stel KJ, Sinniah K, Priola SA, Surewicz WK, Caughey B, Ma J.

PLoS Pathog. 2017 Jul 12;13(7):e1006491. doi: 10.1371/journal.ppat.1006491. eCollection 2017 Jul.

5.

Mitochondrial Respiration Is Impaired during Late-Stage Hamster Prion Infection.

Faris R, Moore RA, Ward A, Sturdevant DE, Priola SA.

J Virol. 2017 Aug 24;91(18). pii: e00524-17. doi: 10.1128/JVI.00524-17. Print 2017 Sep 15.

6.

Cellular prion protein is present in mitochondria of healthy mice.

Faris R, Moore RA, Ward A, Race B, Dorward DW, Hollister JR, Fischer ER, Priola SA.

Sci Rep. 2017 Feb 2;7:41556. doi: 10.1038/srep41556.

7.

PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.

Marshall KE, Hughson A, Vascellari S, Priola SA, Sakudo A, Onodera T, Baron GS.

J Virol. 2017 Jan 3;91(2). pii: e01686-16. doi: 10.1128/JVI.01686-16. Print 2017 Jan 15.

8.

Relative Abundance of apoE and Aβ1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.

Moore RA, Choi YP, Head MW, Ironside JW, Faris R, Ritchie DL, Zanusso G, Priola SA.

J Proteome Res. 2016 Dec 2;15(12):4518-4531. Epub 2016 Sep 30.

PMID:
27597180
9.

Correction: The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.

Moore RA, Head MW, Ironside JW, Ritchie DL, Zanusso G, Choi YP, Priola SA.

PLoS Pathog. 2016 Mar 8;12(3):e1005496. doi: 10.1371/journal.ppat.1005496. eCollection 2016 Mar. No abstract available.

10.

The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.

Moore RA, Head MW, Ironside JW, Ritchie DL, Zanusso G, Choi YP, Priola SA.

PLoS Pathog. 2016 Feb 3;12(2):e1005416. doi: 10.1371/journal.ppat.1005416. eCollection 2016 Feb. Erratum in: PLoS Pathog. 2016 Mar;12(3):e1005496. Pyo Choi, Young [corrected to Choi, Young Pyo].

11.

Treatment of Prion Disease with Heterologous Prion Proteins.

Skinner PJ, Kim HO, Bryant D, Kinzel NJ, Reilly C, Priola SA, Ward AE, Goodman PA, Olson K, Seelig DM.

PLoS One. 2015 Jul 2;10(7):e0131993. doi: 10.1371/journal.pone.0131993. eCollection 2015.

12.

Proteomics applications in prion biology and structure.

Moore RA, Faris R, Priola SA.

Expert Rev Proteomics. 2015 Apr;12(2):171-84. doi: 10.1586/14789450.2015.1019481. Review.

PMID:
25795148
13.

Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.

Choi YP, Head MW, Ironside JW, Priola SA.

Am J Pathol. 2014 Dec;184(12):3299-307. doi: 10.1016/j.ajpath.2014.08.005. Epub 2014 Sep 30.

14.

Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis.

Moore RA, Sturdevant DE, Chesebro B, Priola SA.

J Proteome Res. 2014 Nov 7;13(11):4620-34. doi: 10.1021/pr500329w. Epub 2014 Aug 29.

15.
16.

Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.

Timmes AG, Moore RA, Fischer ER, Priola SA.

PLoS One. 2013 Jul 30;8(7):e71081. doi: 10.1371/journal.pone.0071081. Print 2013.

17.

Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease.

Priola SA, Ward AE, McCall SA, Trifilo M, Choi YP, Solforosi L, Williamson RA, Cruite JT, Oldstone MB.

J Virol. 2013 Sep;87(17):9501-10. doi: 10.1128/JVI.00692-13. Epub 2013 Jun 19.

18.

Rabbits are not resistant to prion infection.

Chianini F, Fernández-Borges N, Vidal E, Gibbard L, Pintado B, de Castro J, Priola SA, Hamilton S, Eaton SL, Finlayson J, Pang Y, Steele P, Reid HW, Dagleish MP, Castilla J.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5080-5. doi: 10.1073/pnas.1120076109. Epub 2012 Mar 13.

19.

Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice.

Leblanc P, Hasenkrug K, Ward A, Myers L, Messer RJ, Alais S, Timmes A, Priola SA.

PLoS One. 2012;7(1):e30872. doi: 10.1371/journal.pone.0030872. Epub 2012 Jan 25. Erratum in: PLoS One. 2012;7(6). doi:10.1371/annotation/c6b9e78a-451b-4a34-bcd3-24a820bfa32f. Priola, Sue [corrected to Priola, Suzette A].

20.

Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure.

Moore RA, Timmes AG, Wilmarth PA, Safronetz D, Priola SA.

Proteomics. 2011 Oct;11(19):3853-65. doi: 10.1002/pmic.201100253. Epub 2011 Sep 7.

21.

Disinfection and sterilization of prion-contaminated medical instruments.

Belay ED, Schonberger LB, Brown P, Priola SA, Chesebro B, Will RG, Asher DM.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1304-6; author reply 1306-8. doi: 10.1086/657579. No abstract available.

PMID:
21047181
22.

Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations.

Moore RA, Timmes A, Wilmarth PA, Priola SA.

Proteomics. 2010 Aug;10(15):2858-69. doi: 10.1002/pmic.201000104.

23.

Susceptibilities of nonhuman primates to chronic wasting disease.

Race B, Meade-White KD, Miller MW, Barbian KD, Rubenstein R, LaFauci G, Cervenakova L, Favara C, Gardner D, Long D, Parnell M, Striebel J, Priola SA, Ward A, Williams ES, Race R, Chesebro B.

Emerg Infect Dis. 2009 Sep;15(9):1366-76. doi: 10.3201/eid1509.090253.

24.

The role of the prion protein membrane anchor in prion infection.

Priola SA, McNally KL.

Prion. 2009 Jul-Sep;3(3):134-8. Epub 2009 Jul 7. Review.

25.

Cells expressing anchorless prion protein are resistant to scrapie infection.

McNally KL, Ward AE, Priola SA.

J Virol. 2009 May;83(9):4469-75. doi: 10.1128/JVI.02412-08. Epub 2009 Feb 18.

26.

Prion protein misfolding and disease.

Moore RA, Taubner LM, Priola SA.

Curr Opin Struct Biol. 2009 Feb;19(1):14-22. doi: 10.1016/j.sbi.2008.12.007. Epub 2009 Jan 20. Review.

27.

Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent.

Greil CS, Vorberg IM, Ward AE, Meade-White KD, Harris DA, Priola SA.

Virology. 2008 Sep 30;379(2):284-93. doi: 10.1016/j.virol.2008.07.006. Epub 2008 Aug 8.

28.

Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1.

Caetano FA, Lopes MH, Hajj GN, Machado CF, Pinto Arantes C, Magalhães AC, Vieira Mde P, Américo TA, Massensini AR, Priola SA, Vorberg I, Gomez MV, Linden R, Prado VF, Martins VR, Prado MA.

J Neurosci. 2008 Jun 25;28(26):6691-702. doi: 10.1523/JNEUROSCI.1701-08.2008.

29.

Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking.

Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA, Caughey B.

Nat Methods. 2008 Mar;5(3):211-2. doi: 10.1038/nmeth0308-211. No abstract available.

PMID:
18309304
30.

Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.

Dirikoc S, Priola SA, Marella M, Zsürger N, Chabry J.

J Neurosci. 2007 Sep 5;27(36):9537-44.

31.

Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity.

Caughey WS, Priola SA, Kocisko DA, Raymond LD, Ward A, Caughey B.

Antimicrob Agents Chemother. 2007 Nov;51(11):3887-94. Epub 2007 Aug 20.

32.

Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein.

Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, Caughey B.

Nat Methods. 2007 Aug;4(8):645-50. Epub 2007 Jul 22.

PMID:
17643109
33.

Amyloid formation via supramolecular peptide assemblies.

Moore RA, Hayes SF, Fischer ER, Priola SA.

Biochemistry. 2007 Jun 19;46(24):7079-87. Epub 2007 May 24.

PMID:
17521170
34.

Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.

Priola SA, Vorberg I.

Mol Biotechnol. 2006 May;33(1):71-88. Review.

PMID:
16691009
35.

Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation.

Moore RA, Herzog C, Errett J, Kocisko DA, Arnold KM, Hayes SF, Priola SA.

Protein Sci. 2006 Mar;15(3):609-19. Epub 2006 Feb 1.

36.

DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity.

Takemura K, Wang P, Vorberg I, Surewicz W, Priola SA, Kanthasamy A, Pottathil R, Chen SG, Sreevatsan S.

Exp Biol Med (Maywood). 2006 Feb;231(2):204-14. Erratum in: Exp Biol Med (Maywood). 2006 Apr;231(4):485.

PMID:
16446497
37.

Identification of possible animal origins of prion disease in human beings.

Priola SA, Vorberg I.

Lancet. 2004 Jun 19;363(9426):2013-4. No abstract available.

PMID:
15207949
38.

Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.

Priola SA, Vorberg I.

Methods Mol Biol. 2004;268:517-40. Review.

PMID:
15156065
39.

Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.

Vorberg I, Raines A, Priola SA.

J Biol Chem. 2004 Jul 9;279(28):29218-25. Epub 2004 May 7.

40.

Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents.

Vorberg I, Raines A, Story B, Priola SA.

J Infect Dis. 2004 Feb 1;189(3):431-9. Epub 2004 Jan 21.

PMID:
14745700
41.
42.

Prophylactic and therapeutic effects of phthalocyanine tetrasulfonate in scrapie-infected mice.

Priola SA, Raines A, Caughey W.

J Infect Dis. 2003 Sep 1;188(5):699-705. Epub 2003 Aug 14.

PMID:
12934186
43.

Biomedicine. A view from the top--prion diseases from 10,000 feet.

Priola SA, Chesebro B, Caughey B.

Science. 2003 May 9;300(5621):917-9. No abstract available.

PMID:
12738843
44.

Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform.

Vorberg I, Groschup MH, Pfaff E, Priola SA.

J Virol. 2003 Feb;77(3):2003-9.

45.

Molecular basis of scrapie strain glycoform variation.

Vorberg I, Priola SA.

J Biol Chem. 2002 Sep 27;277(39):36775-81. Epub 2002 Jul 23.

Supplemental Content

Loading ...
Support Center